ASCO: Sanofi says early amcenestrant data could see it be 'endocrine backbone therapy' in breast ...

Retrieved on: 2021-05-19 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

ASCO: Sanofi says early amcenestrant data could see it be 'endocrine backbone therapy' in breast .... View article details on hiswai:

Excerpt

Roche did, however, dump several SERDs, including its midstage oral attempt ARN-810, which came out from the ill-fated buyout of Seragon back in ...

Article found on: www.fiercebiotech.com